ATE321892T1 - Hiv-nachweisverfahren und reagenzien dafür - Google Patents

Hiv-nachweisverfahren und reagenzien dafür

Info

Publication number
ATE321892T1
ATE321892T1 AT01921607T AT01921607T ATE321892T1 AT E321892 T1 ATE321892 T1 AT E321892T1 AT 01921607 T AT01921607 T AT 01921607T AT 01921607 T AT01921607 T AT 01921607T AT E321892 T1 ATE321892 T1 AT E321892T1
Authority
AT
Austria
Prior art keywords
assays
methods
reagents
virus
viral
Prior art date
Application number
AT01921607T
Other languages
English (en)
Inventor
Joerg-Peter Kleim
Laurence Henry Robinson
Wood Road Gunnells
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9890016&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE321892(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE321892T1 publication Critical patent/ATE321892T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT01921607T 2000-04-14 2001-04-12 Hiv-nachweisverfahren und reagenzien dafür ATE321892T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0009374.0A GB0009374D0 (en) 2000-04-14 2000-04-14 Phenotyping assay and reagents therefor

Publications (1)

Publication Number Publication Date
ATE321892T1 true ATE321892T1 (de) 2006-04-15

Family

ID=9890016

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01921607T ATE321892T1 (de) 2000-04-14 2001-04-12 Hiv-nachweisverfahren und reagenzien dafür

Country Status (8)

Country Link
US (1) US20040038199A1 (de)
EP (1) EP1272676B1 (de)
AT (1) ATE321892T1 (de)
AU (1) AU4857801A (de)
DE (1) DE60118351T2 (de)
ES (1) ES2260212T3 (de)
GB (1) GB0009374D0 (de)
WO (1) WO2001079542A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2244332B1 (es) * 2004-05-10 2007-02-16 Fundacion Para La Investigacion Y La Prevencion Del Sida En España Nuevos clones virales recombinantes basados en vih y su utilizacion en metodos analiticos.
EP2010680A2 (de) * 2006-04-14 2009-01-07 Tibotec Pharmaceuticals Ltd. Verfahren und mittel zur beurteilung von hiv-gag-/proteasehemmer-therapie
GB0701253D0 (en) 2007-01-23 2007-02-28 Diagnostics For The Real World Nucleic acid amplification and testing
WO2010130731A1 (en) * 2009-05-12 2010-11-18 Virco Bvba Hiv-1-c resistance monitoring
CN114574521B (zh) * 2022-03-03 2023-09-12 山东中医药大学 一种基于平衡补偿的重组流感病毒构建方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69712731T2 (de) * 1996-01-26 2003-02-06 Virco Nv Verfahren zur überwachung der chemotherapie von hiv-positiven patienten basierend auf der phenotypischen medikamentempfindlichkeit vom hiv stamm des patienten
GB9909793D0 (en) * 1999-04-28 1999-06-23 Glaxo Group Ltd Improved assay and reagents therefor
EP1185712B8 (de) * 1999-05-28 2005-10-19 Virco Bvba Neue mutationsprofile der hiv-1 reverse transcriptase in verbindung mit phänotypischem medikamentresistenz
EP1109019A1 (de) * 1999-12-15 2001-06-20 BioStrands S.r.l. Verfahren zur Ermittlung der Empfindlichkeit von HIV-Varianten gegen Hemmstoffe der HIV-Protease
AU2001233513A1 (en) * 2000-02-04 2001-08-14 K.U. Leuven Research And Development Hiv-1 resistance assay

Also Published As

Publication number Publication date
DE60118351D1 (de) 2006-05-18
EP1272676A2 (de) 2003-01-08
AU4857801A (en) 2001-10-30
GB0009374D0 (en) 2000-05-31
WO2001079542A3 (en) 2002-06-06
WO2001079542A2 (en) 2001-10-25
DE60118351T2 (de) 2006-11-30
ES2260212T3 (es) 2006-11-01
EP1272676B1 (de) 2006-03-29
US20040038199A1 (en) 2004-02-26

Similar Documents

Publication Publication Date Title
Popper et al. Low plasma human immunodeficiency virus type 2 viral load is independent of proviral load: low virus production in vivo
Mangeat et al. A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to Vif action
Resch et al. Nelfinavir-resistant, amprenavir-hypersusceptible strains of human immunodeficiency virus type 1 carrying an N88S mutation in protease have reduced infectivity, reduced replication capacity, and reduced fitness and process the Gag polyprotein precursor aberrantly
Tran et al. Influenza virus repurposes the antiviral protein IFIT2 to promote translation of viral mRNAs
Defoort et al. Simultaneous detection of multiplex-amplified human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA using a flow cytometer microsphere-based hybridization assay
ATE282720T1 (de) Nukleinsäuresequenzen als primer und sonden zur amplifizierung und erkennung von allen hiv-1 subtypen
Oelrichs et al. The explosive human immunodeficiency virus type 1 epidemic among injecting drug users of Kathmandu, Nepal, is caused by a subtype C virus of restricted genetic diversity
Albertoni et al. Mini review: current molecular methods for the detection and quantification of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1
Contreras-Galindo et al. A new Real-Time-RT-PCR for quantitation of human endogenous retroviruses type K (HERV-K) RNA load in plasma samples: increased HERV-K RNA titers in HIV-1 patients with HAART non-suppressive regimens
Gryadunov et al. Hepatitis C virus genotyping using an oligonucleotide microarray based on the NS5B sequence
Sherpa et al. Evolution of the HIV-1 rev response element during natural infection reveals nucleotide changes that correlate with altered structure and increased activity over time
Sam et al. Validation of a solid-phase electrochemical array for genotyping hepatitis C virus
WO2000066774A3 (en) Improved assay and reagents therefor
Lu et al. Evolution of resistant M414T mutants among hepatitis C virus replicon cells treated with polymerase inhibitor A-782759
ATE321892T1 (de) Hiv-nachweisverfahren und reagenzien dafür
Shuck-Lee et al. Single-nucleotide changes in the HIV Rev-response element mediate resistance to compounds that inhibit Rev function
Wei et al. Simple subtyping assay for human immunodeficiency virus type 1 subtypes B, C, CRF01-AE, CRF07-BC, and CRF08-BC
BRPI0413825A (pt) detecção molecular multialélica de coronavìrus associado com sars
Trémeaux et al. Amplification and pyrosequencing of near-full-length hepatitis C virus for typing and monitoring antiviral resistant strains
Lu et al. Virus–host mucosal interactions during early SIV rectal transmission
Wilber Branched DNA for quantification of viral load
Müller et al. A novel internally controlled real-time reverse transcription-PCR assay for HIV-1 RNA targeting the pol integrase genomic region
Takyar et al. Vitamin B12 stalls the 80 S ribosomal complex on the hepatitis C internal ribosome entry site
BRPI0514156A (pt) método de detecção e quantificação in vitro de dna de hiv através de pcr quantitativa
Hauser et al. Detection and quantification of minor human immunodeficiency virus type 1 variants harboring K103N and Y181C resistance mutations in subtype A and D isolates by allele-specific real-time PCR

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties